The NIH’s human microbiome project | Lita Proctor, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Live Biotherapeutics: How the Vaginal Microbiome Can be Modified to Prevent HIV Infection | Laurel Lagenaur, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Functional Role of Gut Microbiota in Chronic Liver Disease | Gary Wu, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Key note: Systems Biology, Modeling, and Cross-Meta-Omic Analysis of the Human Microbiome | Elhanan Borenstein, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Russian HIV Clinical Series | Anna Maria Geretti | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Russian HIV Clinical Series | Roger Paredes | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Russian HIV Clinical Series | Natalia Litvinova | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Update on DDI guidelines of the FDA - in vitro | Xinning Yang, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Last advances in HIV pharmacogenomics | Andrea Calcagno, MD, DTM&H

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

How/when will pharmacogenomics translate into improved clinical care? | David Haas, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Application of Physiologically based pharmacokinetic (PBPK) Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBA

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

The use of DAA’s in pregnancy in HCV infected mothers | David Burger, PharmD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Viral Dynamics and the Search for an HIV Cure | Stephen Becker, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Clinical Development of Long-Acting Broadly Neutralizing Monoclonal Antibodies: Lessons Learned Thus Far | Richard Koup, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

How to End the Global HCV Epidemic - the role of injectables | David Thomas, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Prevalence of HIV/TB and HIV/Hep B/C Co-Infection in China and Neighboring Countries

Chinese HIV Clinical Forum Educational Series 2020 - 2021

HIV and Pediatrics in Central Europe | Mariana Mărdărescu, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Tackling the issues: Caring for HIV-positive women today | Anna Maria Geretti, MD, PhD, FRCPath

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Panel discussion Session 4

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Drug-Drug Interactions: considerations | Anca Streinu-Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

IVDU | Pavel Khaykin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Discussion panel Session 3

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Update of new drugs | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016